The neurodegenerative disorder Huntington's disease is caused by an expansion in the polyglutamine repeat region of the protein huntingtin. Multiple studies in cellular and animal model systems indicate that this mutation imparts a novel toxic function required for disease pathogenesis. However, the normal function of huntingtin, an essential cellular protein in higher vertebrates, is not yet well understood. Emerging data indicate an important role for wild-type huntingtin in the intracellular transport of vesicles and organelles. Here, we discuss current progress on the role of huntingtin in vesicular trafficking, focusing on the proposal that huntingtin might be a crucial regulator of organelle transport along the cellular cytoskeleton.
Huntingtin: an essential multi-domain protein in health and disease The devastating neurodegenerative disorder Huntington's disease (HD) is caused by a pathogenic expansion of the polyglutamine repeat region of the protein huntingtin. Extensive research has focused on the defects that result from expression of mutant huntingtin (see Ref. [1] for a comprehensive recent review). Expansion of the polyglutamine repeat in huntingtin is clearly toxic to a subset of mammalian neurons; the primary cell types affected in HD are neurons in the striatum and cerebral cortex, which control cognitive and movement functions [2] (Box 1). HD is an autosomal dominant disorder and experiments in multiple cell and animal model systems support the hypothesis that the expansion of the polyglutamine repeat region in huntingtin causes a toxic gain-of-function, meaning that the mutation imparts an additional, deleterious function for the protein, which is not shared by the wildtype form [2] . Pathogenic mechanisms that have been proposed to explain this toxic gain-of-function include protein aggregation, altered gene expression, impaired autophagy and proteasome function, mitochondrial dysfunction leading to accumulation of reactive oxygen species, and increased apoptosis [1] .
However, little is known about the cellular function of wild-type huntingtin. Huntingtin is primarily a cytoplasmic protein, known to be both vesicle-and microtubule-associated [3] [4] [5] . Huntingtin is encoded by a single gene and is ubiquitously expressed in mammals. Knockout of the gene encoding huntingtin is lethal in the mouse early in embryogenesis (approximately embryonic day [E] 8.5), before organogenesis [6] [7] [8] . Expression of huntingtin is also essential for normal development in zebrafish because knockdown by antisense morpholino oligonucleotides leads to multiple developmental abnormalities, including defects in cellular iron trafficking [9] . Huntingtin is not expressed in lower eukaryotes such as yeast.
Huntingtin is a multi-domain protein that is thought to have multiple distinct cellular roles. Proposed cellular functions include transcriptional regulation, nucleo-cytoplasmic shuttling, synaptic function and anti-apoptotic activity; the data supporting these possibilities have recently been reviewed in [1] and will not be discussed further here. Instead, we focus on a possible function for huntingtin in vesicular trafficking and transport in the cell.
Recent developments in our understanding of the cytoplasmic function of huntingtin have led to new insights into the role of this protein as an integrator of vesicular trafficking. Accumulating data on roles for huntingtin in endocytosis, endosomal motility and axonal transport have led to an emerging model for huntingtin as an integrator of transport along the cellular cytoskeleton. Given that a growing number of mutations in trafficking proteins are causally linked to neurodegenerative diseases [10] , it is reasonable to propose that defects in normal huntingtin function caused by polyglutamine repeat expansion might contribute to disease progression or severity. Improved understanding of this aspect of HD pathogenesis might therefore provide useful insight for the design of targeted therapeutic interventions in future.
Huntingtin builds a network of interactions with motor and motor-associated proteins Huntingtin interacts with a diverse array of cellular proteins through multiple interaction domains (for a review, see Refs [11, 12] ; Figure 1 ). There are predicted to be up to 36 HEAT repeats spanning most of the huntingtin polypeptide; HEAT repeats are a helix-loop-a helix motifs that mediate protein-protein interactions [13] . Overall, the predicted structure of huntingtin is consistent with a cellular role as a scaffold protein. Several motifs within the polypeptide have been suggested to mediate attachment to membranes. An N-terminal membraneassociation signal (amino aids 1-18) has been proposed to confer the reversible association of huntingtin with the endoplasmic reticulum, late endosomes and autophagosomes [14] ; amino acids 172-372 have been shown to associate with acidic phospholipids at the plasma membrane [15] ; and palmitoylation of Cys214 by HIP14, a huntingtin-interacting protein that functions as a palmitoyl transferase, might also affect huntingtin localization in the cell [16] .
Several of the known binding partners for huntingtin are involved in vesicle trafficking and intracellular transport ( Figure 1 ). Huntingtin-associated protein 1 (HAP1) is a huntingtin-binding partner that has been proposed to facilitate interactions with microtubule motor proteins. HAP1 is associated with the plus-end-directed microtubule motor protein kinesin, as shown by multiple biochemical techniques [17, 18] .
An interaction between HAP1 and the p150 Glued subunit of dynactin was also identified in a yeast two-hybrid screen and verified in biochemical assays [19, 20] . Dynactin is an essential co-factor for the transport of membranous organelles by the minus-end-directed microtubule motor cytoplasmic dynein. Although HAP1 has not yet been shown to bind to either kinesin or dynactin directly, co-immunoprecipitation experiments indicate the formation of an endogenous complex of HAP1, kinesin and dynactin [21] .
Biochemical evidence indicates that there is a direct interaction between huntingtin and cytoplasmic dynein, as demonstrated initially in a yeast two-hybrid screen and verified by the direct binding of purified cytoplasmic dynein to a recombinant fragment of huntingtin [22] . Mapping experiments identify a binding site for the dynein intermediate chain to residues 601-698 of huntingtin. Immunoprecipitation of endogenous proteins from brain extract with an anti-dynein antibody demonstrates the coprecipitation of a complex that includes cytoplasmic dynein, dynactin, huntingtin, kinesin and HAP1 [22] , further supporting the hypothesis that huntingtin interacts with both plus-end-directed and minus-end-directed microtubule motor proteins.
In addition to these interactions with microtubulebased motors, huntingtin is also linked to actin-based motors through optineurin [23] (Figure 1 ), a protein that links myosin VI to Golgi membranes [24] . This observation, along with those of Pal et al. [25] (discussed later), raises the possibility that huntingtin can integrate intracellular trafficking along both the microtubule and actin cytoskeletons.
Studies of mutant huntingtin pave the way for analyses of wild-type huntingtin function The polyglutamine repeat expansion mutation in the gene encoding huntingtin causes misfolding and cellular accumulation of the protein, including aggregate formation. Typically, efficient clearance of misfolded and aggregated proteins by the cell depends on trafficking of membranous cargo along the cellular cytoskeleton. Accumulation of aggregates could indicate either an inability to degrade the mutant protein or, alternatively, could indicate an overall inhibition of the cellular trafficking and degradative machinery. Increasingly, defects in components of this cellular machinery are being implicated as direct causes of neurodegenerative disease [10] .
One indication that striatal neurons, a neuronal population that is severely affected in HD, suffer from defective intracellular trafficking is that the levels of brain-derivedneurotrophic factor (BDNF) are decreased in these cells owing to expression of mutant huntingtin [26, 27] . In the corticostriatal neuronal circuit, BDNF is secreted by cortical neurons and endocytosed by striatal neurons [28] . Striatal neurons require BDNF for survival [29] and perturbations in BDNF trafficking could be devastating to these cells.
Together, these observations suggest that the polyglutamine expansion in mutant huntingtin can detrimentally affect the trafficking and degradation of the mutant polypeptide, but can also act more broadly to poison trafficking pathways in the cell, including the trafficking of neurotrophic factors such as BDNF.
In fact, studies have demonstrated that mutant huntingtin causes defective axonal trafficking in multiple model organisms, including squid, Drosophila and mice. To assess the effect of mutant huntingtin on vesicle transport, truncated huntingtin constructs containing the disease-causing expanded polyglutamine repeat region were added to vesicles isolated from squid. Decreased bidirectional motility of vesicles was observed in the presence of Box 1. The pathogenesis of Huntington's disease Huntington's disease (HD) is one of a group of approximately 16 disorders that are caused by the expansion of CAG repeats within otherwise unrelated genes. Other trinucleotide repeat disorders affecting the nervous system include ataxias (SCA1-3, 6, 7), spinal bulbar muscular atrophy (SBMA) and fragile X syndrome (FRAXA and FRAXE) [49] . HD is an autosomal dominant disease, meaning that a single copy of the mutant gene with an expanded CAG repeat region within exon 1 is sufficient to induce the disorder. Normal alleles of the gene encoding huntingtin include up to 35 tandem CAG codons, encoding glutamine residues ( Figure 1) ; expansion of this repeat region to encode 36-50 or more glutamine residues is causative for HD. The number of repeats is the key determining factor in age of onset [50] . Longer repeats are genetically unstable and families with HD show anticipation, in which disease severity increases and age of onset decreases over the generations.
HD is typically an adult-onset neurodegenerative disease, leading to striking loss of striatal medium spiny neurons. However, additional changes are also apparent in the diseased brain, including pronounced cortical degeneration [51] and hypothalamic degeneration [52] , and so the dogma that Huntington's disease is a disease of the striatum is being challenged. Clinically, the disease is characterized by complex and variable symptoms that include chorea (spasmodic, irregular muscle contractions), dystonia (involuntary muscle contractions leading to twisting and repetitive movements and abnormal posture), and psychiatric (depression, apathy and irritability) and cognitive deficits. The juvenile form (caused by CAG expansions usually 70 and above) of the disease typically presents with Parkinsonian rigidity and can include epileptic seizures, tremor and myoclonus.
The dominant inheritance pattern seen in HD, along with numerous studies in animal and cellular model systems, support the hypothesis that expression of mutant huntingtin with expanded polyglutamine repeats is toxic to the cell. There is currently little consensus as to the mechanism of toxicity, which might in fact involve multiple pathogenic pathways [49] . There is evidence for the generation of aberrant cleavage fragments, along with aberrant nuclear accumulation of the cleaved fragments. There is also evidence from multiple studies that expression of mutant huntingtin alters transcription [49] . Additional possibilities to explain the neurodegeneration that occurs in HD include mitochondrial dysfunction, altered calcium signaling and excitotoxicity; other mechanisms have also been proposed. Finally, there is accumulating evidence that expression of mutant huntingtin leads to altered intracellular trafficking and transport that is likely to contribute to disease pathogenesis.
mutant huntingtin compared with controls [30] . An analysis of a Drosophila model of HD, created by expressing exon 1 of mutant huntingtin containing the expanded polyglutamine repeat region also revealed defects in axonal transport. The soluble pool of motor proteins was decreased in these flies, leading to the suggestion that the expression of mutant huntingtin caused a depletion of active motors by sequestering dynein, dynactin and kinesin into aggregates [31] .
In embryonic striatal neurons isolated from transgenic mice expressing huntingtin with an expanded polyglutamine repeat region, McMurray and colleagues observed inhibition of vesicular transport in both the anterograde (outward from the cell body) and retrograde (toward the cell body) directions [32] . Mitochondrial transport was also significantly slower in neurons from transgenic mice relative to wild type and was characterized by frequent pauses and a reduction in distance traveled in either direction [32] . To elucidate the mechanism responsible for these defects, the group analyzed extracts from human control and HD brain tissue. They demonstrated from gel filtration and fractionation experiments that components of both kinesin and dynein-dynactin associate with mutant huntingtin. Based on their observations, the authors suggested that poorly soluble protofibrillar complexes of mutant huntingtin found in HD brain can sequester motor proteins, thus depleting the soluble pool available to drive intracellular transport [32] .
To study the cell-type specificity of the transport deficit caused by expression of mutant huntingtin, Her and Goldstein [33] compared the motility of APP-YFP (fluorescently labeled amyloid precursor protein, a well-characterized marker for anterograde axonal transport) and BDNFmCherry fusion proteins in striatal, hippocampal and cortical neurons cultured from mutant mice expressing huntingtin with expanded polyglutamine repeats. They found cell-type-specific differences indicating that intracellular transport in both striatal and hippocampal neurons is sensitive to expression of mutant huntingtin, whereas transport in cortical neurons is not affected [33] . However, cortical neurons were sensitive to loss of huntingtin, and overexpression of wild-type huntingtin stimulated transport in all neuronal cell types tested, consistent with the results of Gauthier et al. [27] .
Together, these observations indicate that expression of mutant huntingtin has deleterious effects on intracellular transport. Proposed mechanisms to explain this inhibition include the depletion of soluble motor pools through an association with protofibrillar complexes or intracellular aggregates of mutant huntingtin. Alternatively, inhibition of transport might be indirect, perhaps caused by altered regulation of motor function or, potentially, by a generalized metabolic defect such as depletion of cellular energy stores. However, the observed deficits might arise because the polyglutamine expansion associated with disease causes a disruption in the normal function of huntingtin required for intracellular transport. To answer these questions, studies focusing on elucidating the role of wild-type huntingtin in vesicle trafficking within the cell are required.
Insight into huntingtin function from knockout and knockdown studies Knockout of the gene encoding huntingtin is embryonic lethal in the mouse [6] [7] [8] , whereas mice with a single copy of the mouse Hdh gene are grossly normal [7] ; however, one line has been reported to display minor cognitive deficits and hyperactivity [6] . Tissue-specific depletion of huntingtin in the forebrain results in progressive neurodegeneration, which is consistent with a post-developmental role for huntingtin in neurons [34] . By contrast, genetic ablation of HAP1 has shown that expression of this protein is not Figure 1 . Schematic of huntingtin. Features relevant to membrane association and binding sites for molecular motor and motor-associated proteins are denoted. The Nterminal membrane localization signal (aa1-18) is shown in green and the polyglutamine repeat region (beginning at aa17) is shown in red. Normal huntingtin contains 35 or fewer polyglutamines, whereas expansion of the repeat region to encode 36 or more glutamine residues results in HD. There are 36 predicted HEAT repeats that span the length of most of the molecule (light blue and light gray regions). The blue region (aa172-372) has been shown to associate with acidic phospholipids at the plasma membrane. The site of palmitoylation of Cys214 by HIP14 is indicated by a blue lollipop and phosphorylation of Ser421 is indicated by a yellow lollipop. The myosin VI linker protein optineurin is known to associate with the N-terminal region of huntingtin. HAP1 interacts with the N-terminal region of normal huntingtin and the expanded polyglutamine repeat found in mutant huntingtin has been shown to enhance binding [48] . HAP1 also interacts with the plus-end-directed microtubule motor kinesin and dynactin. The minus-end-directed microtubule motor dynein interacts with huntingtin (aa600-698) and with the dynein activator dynactin. HAP40, an effector of the small GTPase Rab5, binds to the C-terminal region of huntingtin. [35] . HAP1 knockout mice display early postnatal lethality from depressed feeding behavior owing to hypothalamic dysfunction, but further studies have shown that HAP1 is not required in adult neurons [36] . Thus, whereas huntingtin has an essential cellular role, the interacting protein HAP1 is non-essential, potentially owing to functional redundancy.
Review
Several studies have examined the cellular effects owing to a knockout or knockdown of huntingtin expression. A careful study of subcellular organelle structure and function in embryonic stem cells cultured from a homozygous huntingtin knockout mouse showed that these cells had defects in endoplasmic reticulum extension to the cell periphery, mitochondrial localization, transferrin receptor recycling and Golgi organization [37] . These observations support a role for huntingtin in intracellular membrane trafficking. Mitochondrial motility was examined in cells with a >50% decrease in huntingtin expression relative to wild-type levels [32] . An increase in pausing, a decrease in velocity and a decrease in bidirectional motility are associated with decreased huntingtin expression -which is similar to the defects induced by the expression of mutant huntingtin. Similar observations were made upon ablation of the huntingtin gene in primary cortical cultures from mouse because a depletion of huntingtin to <25% of normal levels results in decreased transport velocity of the reporter construct APP-YFP [33] .
Further insight comes from a study that dissected the parts played by normal huntingtin and HAP1 in vesicular trafficking [27] . Humbert, Saudou and coworkers developed an assay to measure the dynamics of vesicle transport, focusing on the motility of post-Golgi secretory vesicles labeled with green fluorescent protein (GFP)-BDNF [27] . By co-transfecting neuroblastoma cells with GFP-BDNF and either wild-type or mutant huntingtin, they demonstrated that overexpression of wild-type huntingtin enhances BDNF transport. Furthermore, cells depleted of huntingtin by siRNA exhibited a decrease in vesicle velocity and an increase in the number of stationary vesicles and the number of pauses during vesicle transport. These observations provide further evidence that wild-type huntingtin functions to enhance vesicular transport.
To examine whether neuronal BDNF transport was affected by expression of mutant huntingtin, the investigators used neuronal cell lines containing an expanded polyglutamine repeat region inserted into endogenous, full-length huntingtin. They observed a decrease in intracellular BDNF transport, which was rescued by expression of exogenous wild-type huntingtin, indicating that mutant huntingtin acts as a loss-of-function mutation with respect to BDNF transport. To define the mechanism by which huntingtin might enhance transport, the investigators focused on the role of HAP1 because it is known to interact with dynactin [19, 20] . Cells were depleted of HAP1 by siRNA and, again, an inhibition of BDNF trafficking was observed, indicating that huntingtin and HAP1 function in the same pathway to mediate transport of BDNF-bearing vesicles.
Together, these results from knockdown and knockout studies indicate that huntingtin actively participates in intracellular vesicular trafficking. HAP1 probably participates in this pathway but is unlikely to be required because expression of HAP1 does not seem to be essential in adult neurons [36] . Observations to date also indicate that expression of mutant huntingtin is sufficient to induce defects in intracellular trafficking and that these cellular defects can contribute to the neurodegeneration characteristic of HD.
Recently, three strong models have emerged to explain the role of huntingtin in vesicular transport. We review each of these models and then develop a consensus mechanism that might help to guide further work in this area.
Model 1: huntingtin phosphorylation is a molecular switch for microtubule-based bidirectional transport Two recent studies have proposed that huntingtin is a molecular switch that affects the direction of transport of motile vesicles in neurons [18, 38] (Figure 2a) . The motility of post-Golgi secretory vesicles labeled with BDNF-GFP was analyzed to examine the effects of huntingtin phosphorylation in primary neuronal cultures. Depletion of endogenous huntingtin resulted in a bidirectional inhibition of the transport of BDNF-labeled vesicles; transport was restored to normal levels by expression of a huntingtin construct spanning residues 1-480 of wild-type huntingtin [18] .
Previous studies have found that activation of the insulin growth factor 1 (IGF-1)/protein kinase B (Akt) pathway is protective for neurons expressing mutant huntingtin, and it has been proposed that this protective effect was mediated via the phosphorylation of huntingtin on Ser421 [39] . To evaluate the effects of huntingtin phosphorylation on transport, Colin et al. [18] compared the effects of expressing a phosphomimetic construct (Ser421D) to an unphosphorylatable construct (Ser421A). A significant difference was noted in the parameters of vesicle motility along the microtubule: expression of Ser421D huntingtin resulted in faster velocity and longer runs in the anterograde direction and expression of Ser421A huntingtin favored faster velocities and longer runs in the retrograde direction. Thus, it was proposed that phosphorylation of huntingtin at Ser421 is a directional switch, leading to a net change in direction from retrograde (minus-end directed) to anterograde (plus-end directed) motility of vesicles along microtubules. The directional change was not limited to BDNF-GFP vesicles because similar results were observed for the net movement of synaptic vesicles and also the kinesin-associated cargo APP [18] .
To explain the mechanism behind this molecular switch, Colin et al. [18] performed subcellular fractionation studies, which indicate that phosphorylation of huntingtin recruits more kinesin to vesicles. They also examined the association of proteins with phosphorylated huntingtin (phuntingtin). It is known, for instance, that HAP1 is associated with the kinesin light chain [17] ; one hypothesis might be that phosphorylation of huntingtin would lead to an enhanced interaction with HAP1, which in turn would lead to enhanced recruitment of kinesin, ultimately leading to a change in the net directionality of transport. However, Colin and colleagues show that expression of the Ser421D fragment of huntingtin does not in fact increase the amount of associated HAP1 [18] . Instead, they found that expression of this phosphomimetic construct led to an increased association between kinesin and dynactin, thereby indicating that p-huntingtin stabilizes an interaction between these proteins.
Future experiments are needed to provide a detailed explanation of the molecular switch observed in these experiments. First, why an increased recruitment of dynactin might favor plus-end-directed transport remains Figure 2 . Three models for huntingtin might act as a scaffold to coordinate the interplay of various molecular motor and motor-associated proteins to facilitate vesicular transport along the cytoskeleton. (a) Huntingtin phosphorylation is a molecular switch. When huntingtin is phosphorylated at Ser421, kinesin is recruited to vesicles and anterograde vesicle motility towards the microtubule towards the plus end predominates. In the unphosphorylated state, kinesin recruitment to the vesicle is no longer stabilized and dynein-dynactin-mediated retrograde motility towards the minus end predominates. (b) The huntingtin-HAP40 complex on Rab5-associated endosomes is a switch for cytoskeletal affinity between actin and microtubules. When there is an increase in cytoplasmic levels of HAP40, the early endosome positive for Rab5 is able to associate with actin, possibly through a linker, such as optineurin, that binds to myosin VI. When HAP40 levels are decreased, Rab5-positive early endosomes bind to the microtubule. (c) Huntingtin coordinates cytoskeletal vesicle transport. When endocytic cargo traverses the actin cytoskeleton, huntingtin might mediate vesicle attachment to actin via a myosin adaptor protein as in (b). Upon loss of HAP40, and perhaps binding of HAP1, microtubule affinity is enhanced; additional regulatory events, such as phosphorylation of huntingtin as in (a), influence which microtubule motor will predominate and contribute to the directionality of transport. to be determined. Although kinesin-1 (conventional kinesin) and dynein interact directly [40] and an association between kinesin-2, a distinct member of the kinesin superfamily, and dynactin has also been characterized [41] , biochemical studies to date have not provided evidence for a direct interaction between kinesin-1 and dynactin. One hypothesis is that phosphorylation of huntingtin enhances the association of kinesin and dynein, and this is detected indirectly as an increased recruitment of dynactin in the work by Colin et al [18] . An alternative hypothesis is that phosphorylation of huntingtin might recruit kinesin to the vesicle through an as yet unidentified effector molecule. The prediction is that an increased ratio of kinesin to dynein motors on the vesicle will enable kinesin to win a tug-of-war, resulting in the net movement of the vesicle towards the plus end of the microtubule. In the absence of huntingtin phosphorylation, dynein will dominate, resulting in net movement towards the microtubule minus end at the cell center.
To assess the role of this regulatory mechanism in the context of the mutant form of huntingtin, Zala and colleagues compared the effects of overexpression of either wild-type or mutant huntingtin on vesicular transport [38] . They found that only wild-type huntingtin was capable of stimulating transport of BDNF-labeled vesicles; Her and Goldstein [33] report similar results for the transport of APP-associated vesicles. However, if the mutant huntingtin construct also included the phosphomimetic Ser421D mutation, then normal bidirectional vesicle transport was restored. Treatment of neurons expressing mutant huntingtin with IGF-1, or co-transfection with constitutively active Akt, also rescued transport defects [38] , indicating that mis-regulation of transport could be a crucial aspect of the defects induced by expansion of the polyglutamine repeats found in HD.
Model 2: huntingtin-HAP40 is a switch for cytoskeletal affinity Endosomal membrane fusion and targeting is regulated by Rab GTPases. Rab5 specifically associates with early endosomes and regulates the motility of early endosomes along microtubules [42] . Pal et al. [25] have recently shown that huntingtin forms a complex with a Rab5 effector that induces a change in the cytoskeletal affinity of early endosomes (Figure 2b ). The ability of vesicles to switch from actin, which is most often used for short-range transport, to microtubules, which are used for long-distance transport, and vice versa, is a key feature of vesicle transport that is not yet fully understood. Using both in vitro and in vivo assays, the authors showed that huntingtin promotes a change in endosome association from microtubules to actin through an interaction with an additional huntingtin-binding protein, HAP40.
Using in vitro reconstitution assays, addition of recombinant HAP40 or of an eluate from a Rab5 affinity column that contained both huntingtin and HAP40 decreased endosomal motility along microtubules. Microtubuleand actin-binding assays revealed that HAP40 or the huntingtin-HAP40 complex decreased binding of endosomes to microtubules while enhancing binding to actin filaments.
In transfected HeLa cells overexpressing HAP40, Rab5-GFP-positive early endosomes showed a decreased rate of mobility compared with endosomes in cells transfected with Rab5-GFP alone. In addition, primary fibroblasts from HD patients had an 10-fold increase in the level of HAP40 expression and displayed impaired mobility of Rab5-GFP endosomes in comparison with controls. Immunocytochemistry demonstrated that the HD cells had fewer Rab5-GFP endosomes associated with microtubules compared with control cells. Instead, the Rab5-GFP endosomes were observed in a linear array along actin filaments. These results support a role for huntingtin in modulating the affinity of early endosomes for the cytoskeleton through its interaction with the effector HAP40 and indicate a mechanism by which vesicle trafficking could be perturbed in patients with HD. The upregulation of HAP40 might lead to the re-direction of intracellular vesicular traffic from microtubules to actin. Because actinbased transport usually results in shorter, more dispersive motility in the cell, a relative increase in actin-bound vesicles in HD could result in a defect in long-range transport, driven by microtubule-associated motors. Thus, a mis-regulation of HAP40 expression could lead to general dysfunction of endosomal trafficking pathways.
Although these observations have led to an intriguing model, many questions remain. It remains unclear how the huntingtin-HAP40 complex enhances the affinity of Rab5-positive vesicles for actin filaments. One possible mechanism could involve optineurin, an adaptor protein that links huntingtin to the actin-based motor myosin VI [24] . Could the binding of HAP40 to the huntingtin complex on an early endosome favor recruitment of a myosin adaptor similar to optineurin, resulting in motility along the actin cytoskeleton? Furthermore, dissociation of HAP40 from the huntingtin complex might function as a regulatory switch during endocytosis or post-Golgi trafficking. This in turn would promote a switch from motility along actin to transport along microtubules, promoting a change from short-range to long-range vesicular transport.
Another important question that remains to be answered is how mutant huntingtin, the cause of HD, might cause an upregulation of HAP40: Pal and colleagues suggest transcriptional abnormalities that arise from expression of huntingtin with expanded glutamine repeats to be the most likely answer [25] . An in-depth analysis of gene expression data from HD cells might provide confirmation of this hypothesis, although changes in HAP40 levels were not noted in a recent microarray analysis [43] that examined changes in gene expression in huntingtin-null mouse embryonic fibroblasts. Another possible mechanism for an increase in HAP40 levels in HD cells might be a decrease in protein turnover owing to trafficking defects in the presence of mutant huntingtin, but a direct link between inhibition of protein degradation and expression of mutant huntingtin has not been well established yet [1] .
Model 3: huntingtin facilitates dynein-mediated vesicle motility
We recently demonstrated that huntingtin binds directly to dynein to enhance dynein-mediated vesicle motility along microtubules [22] (Figure 2c ). HeLa cells depleted of huntingtin by RNAi exhibited partial disruption of Golgi stacks, a hallmark for defective dynein function. A similar disruption of Golgi organization induced by depletion of endogenous huntingtin was recently reported by Del Toro et al. [44] .
As the most important minus-end-directed motor for vesicular motility, cytoplasmic dynein is responsible for the transport of a myriad of membranous organelles [45] . Through a direct interaction with the dynein intermediate chain, huntingtin might facilitate dynein-mediated trafficking of many types of vesicles. In support of this, we saw that interfering with huntingtin function through the addition of function-blocking antibodies to a cell-free assay for vesicular transport caused a heterogeneous population of vesicles enriched for dynein to detach from microtubules, whereas those that remained bound exhibited defective bidirectional transport [22] .
There is now ample evidence that the role of huntingtin in facilitating membrane transport is not limited to the transport of a specific organelle. Huntingtin phosphorylation induced a change in direction of both post-Golgi secretory vesicles and synaptic vesicles [18] . Also, accumulating evidence indicates that depletion of huntingtin affects both early endosomes and downstream recycling compartments. A recent study in zebrafish demonstrated that knockdown of huntingtin resulted in defective iron use. Embryos were able to endocytose iron, but subsequent defects in iron trafficking led to decreased hemoglobin production [9] . An earlier study of cultured embryonic cells from the huntingtin-knockout mouse demonstrated a defect in transferrin recycling [37] , further supporting a role for huntingtin in the trafficking of the recycling endosome. A more recent finding that huntingtin is a Rab11-associated protein affecting Rab11 GDP-GTP exchange factor (GEF) activity supports a role for huntingtin in regulating recycling compartments [46] but more work is clearly required. Finally, a recent study has shown that expression of mutant huntingtin results in an impairment of optineurin-dependent post-Golgi trafficking to lysosomes and a subsequent deficit in lysosomal activity [44] . Together, these observations indicate that huntingtin is involved in the transport of multiple types of membranous cargo throughout the cell.
Huntingtin, a global coordinator of cytoskeletal vesicular transport? We propose that huntingtin facilitates global vesicular trafficking throughout the multiple cytoskeletal superhighways of the cell. Huntingtin is able to coordinate the binding of multiple types of motor proteins to vesicular cargo, most probably by acting as a scaffold that can differentially bind to many proteins. By integrating various signals, huntingtin might have a key role in modulating vesicle transport between the actin and microtubule cytoskeletons (Figure 2c) .
After internalization from the plasma membrane, endocytic vesicles initially traverse the actin-rich cell cortex. The huntingtin-HAP40 complex might regulate vesicle association with actin [25] . Through associations with a myosin VI linker protein, such as optineurin [24] , huntingtin could have a role in actin-based transport of endocytic vesicles early in endocytosis. Myosin VI is the only myosin identified as yet to move towards the minus end of the actin filament and it has been shown to have a role in trafficking of clathrin-coated vesicles [47] .
After undergoing short-range transport along the actin cytoskeleton, endosomes are delivered to microtubules for long-distance transport. Huntingtin might mediate this cytoskeletal switching through a dissociation of HAP40; this is perhaps followed by a concomitant increase in HAP1 binding, which would favor microtubule-association over actin-association. Huntingtin then facilitates dyneinmediated vesicular transport along microtubules through direct binding to dynein and indirect binding to dynactin via HAP1. This possibly leads to the formation of a quaternary complex that enhances interactions of various effectors [22] .
Continuing with the example of endosomal cargo, once an internalized receptor that is fated to be recycled back to the plasma membrane has been sorted to a recycling compartment, it requires a change in microtubule motors to cause a switch in the direction of vesicle motility. Huntingtin could serve as this switch through differential binding to downstream effectors. Huntingtin-associated vesicles might also be able to switch direction if increased levels of HAP1 cause an enhanced recruitment of kinesin through the HAP1-kinesin interaction [17] . Alternatively, phosphorylation of huntingtin might cause a recruitment of kinesin to vesicles and a switch in the preferred direction of vesicular motility [18] .
In summary, there is a growing body of evidence that huntingtin serves as a facilitator of vesicle motility along the cellular cytoskeleton. Either depletion of endogenous huntingtin or expression of mutant huntingtin has been shown by multiple laboratories to affect numerous aspects of intracellular trafficking and transport. By integrating the interplay of various binding partners and regulatory pathways, such as phosphorylation, huntingtin can coordinate vesicle binding to the appropriate molecular motor and enhance motility.
Several aspects of huntingtin function in vesicle transport remain less clear (Box 2). For instance, exactly how is huntingtin associated with vesicular membranes? Do posttranslational modifications of huntingtin, such as phosphorylation or palmitoylation by huntingtin-interacting protein HIP14 [16] , affect its ability to enhance vesicle transport? Do these modifications vary depending on the type of membranous cargo, cell type and stage of development? Huntingtin is most probably regulated spatially and temporally and the exact mechanism by which huntingtin enhances vesicle transport will probably vary depending on these parameters. Furthermore, because depletion of huntingtin impairs but does not completely block intracellular trafficking, compensatory mechanisms or parallel pathways are likely to contribute and must be explored.
Elucidation of the role of huntingtin in vesicular transport will potentially shape the future studies of the molecular mechanism underlying HD. Does expansion of the polyglutamine repeat region of huntingtin lead to the inhibition of normal huntingtin function, thus causing or contributing to neurodegeneration? Can altering the phosphorylation state of huntingtin or the expression levels of HAP40 rescue neurodegeneration? Certainly, characterizing the normal function of huntingtin adds to our understanding of HD pathology and will ultimately lead to more targeted therapeutic approaches.
